Registered entities
Switch Therapeutics Inc.
Reg. No. 845049584United States
Switch Pharmaceuticals OÜ
Reg. No. 16330870Estonia
Innovation
8 patent families — focus: Chemistry & metallurgy, Physics & computing; filing pace accelerating. Cited 92 times.
| Year | Filings |
|---|---|
| 2023 | 8 |
| 2024 | 6 |
| 2025 | 6 |
| 2026 | 1 |
Social engagement
Social engagement: 3.5K social following, 6 posts in the last 12 months — below the industry typical range.
Investor mix
15 investors on record; lead investors include Tullis Health Investors, Insight Partners, UCB Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 10 | 67% |
| Private equity | 3 | 20% |
| Accelerator & incubator | 1 | 7% |
| Other / undisclosed | 1 | 7% |
Recent activity
8 Jan 2026
Recognition
1 Dec 2025
Event
Piper Sandler Healthcare Conference
26 Nov 2025
Event
Clinical Trials on Alzheimer's Disease (CTAD) Conference